These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38278367)

  • 1. Anti-stromal nanotherapeutics for hepatocellular carcinoma.
    Yu Z; Huang L; Guo J
    J Control Release; 2024 Mar; 367():500-514. PubMed ID: 38278367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.
    Sas Z; Cendrowicz E; Weinhäuser I; Rygiel TP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
    Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
    J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the microenvironment in hepatocellular carcinoma development and progression.
    Wu SD; Ma YS; Fang Y; Liu LL; Fu D; Shen XZ
    Cancer Treat Rev; 2012 May; 38(3):218-25. PubMed ID: 21763074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma.
    Coulouarn C; Clément B
    J Hepatol; 2014 Jun; 60(6):1306-9. PubMed ID: 24530649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.
    Yin Z; Jiang K; Li R; Dong C; Wang L
    Mol Cancer; 2018 Dec; 17(1):178. PubMed ID: 30593276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.
    Chen C; Wang Z; Ding Y; Qin Y
    Front Immunol; 2023; 14():1133308. PubMed ID: 36845131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the Role of Mechanical Microenvironment in Hepatocellular Carcinoma: Molecular Mechanisms and Implications for Therapeutic Strategies.
    Hong J; Yu J; Buratto D; Chen W; Zhou R; Ling S; Xu X
    Int J Biol Sci; 2024; 20(13):5239-5253. PubMed ID: 39430235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Yan Z; Tong P; Xia Q; He K
    Cell Oncol (Dordr); 2023 Dec; 46(6):1595-1604. PubMed ID: 37414962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy.
    Guizhen Z; Guanchang J; Liwen L; Huifen W; Zhigang R; Ranran S; Zujiang Y
    Front Endocrinol (Lausanne); 2022; 13():918869. PubMed ID: 36093115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression.
    Kotsari M; Dimopoulou V; Koskinas J; Armakolas A
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma.
    Shen C; Li M; Duan Y; Jiang X; Hou X; Xue F; Zhang Y; Luo Y
    Front Immunol; 2023; 14():1170207. PubMed ID: 37304265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
    Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
    Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment.
    Manka P; Coombes JD; Boosman R; Gauthier K; Papa S; Syn WK
    Cancer Lett; 2018 Apr; 419():175-186. PubMed ID: 29414304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
    Liu YC; Yeh CT; Lin KH
    Cells; 2020 May; 9(6):. PubMed ID: 32466488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.